ReviewCurrent neurology and neuroscience reports2025
Sensors in Multiple Sclerosis.
Review in Current neurology and neuroscience reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Walking as a Window to the Brain: Redefining Gait in Neurology.Medical sciences (Basel, Switzerland) · 2026Review
- Associations of Physical Activity, Muscle Mass and Protein-Rich Food Consumption with Functional Fitness in Individuals with Multiple Sclerosis.Nutrients · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
purpose of reviewBiosensors and digital tools may enhance monitoring of people with multiple sclerosis (MS) and support timely, data-driven clinical decisions. We review current and emerging applications of biosensors to monitor function in MS. RECENT RINDINGS: Biosensors track diverse physiological and kinetic metrics, allowing assessment of function across several key domains in MS, including physical activity, circadian rhythmicity, gait, balance, fine motor function, and bladder control. A consistent cross-study finding is that novel technologies reliably capture subtle abnormalities that are often missed by traditional assessment methods. Digital health technologies hold significant promise for transforming MS care by enabling precise, continuous monitoring of functional status and disease progression. They may facilitate personalized management, allowing clinicians to tailor interventions based on each person's unique disease trajectory. Further studies are essential to validate the predictive value and responsiveness of these tools and ensure their effective integration into clinical practice and trials.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.